Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected childrenJoseph A. Church, Prakash Sista, Lynette Purdue et al.|The Pediatric Infectious Disease Journal|2002Cited by 44
Long Term Tolerability and Safety of Enfuvirtide for Human Immunodeficiency Virus 1-Infected ChildrenJoseph A. Church, Coleen K. Cunningham, Michael Hughes et al.|The Pediatric Infectious Disease Journal|2004Cited by 42
Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infectionSibylle Grub, Karin Jorga, Patricia DeLora et al.|Clinical Pharmacology & Therapeutics|2002Cited by 34
Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infectionMark W. Kline, Franck Le Duff, Richard C. Brundage et al.|The Pediatric Infectious Disease Journal|2001Cited by 23